ID   PA24F_HUMAN             Reviewed;         849 AA.
AC   Q68DD2; Q6ZMC8;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   15-FEB-2017, entry version 103.
DE   RecName: Full=Cytosolic phospholipase A2 zeta;
DE            Short=cPLA2-zeta;
DE            EC=3.1.1.4;
DE   AltName: Full=Phospholipase A2 group IVF;
GN   Name=PLA2G4F;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 201-849 (ISOFORM 3), AND
RP   VARIANT VAL-740.
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
CC   -!- FUNCTION: Calcium-dependent phospholipase A2 that selectively
CC       hydrolyzes glycerophospholipids in the sn-2 position. Has higher
CC       enzyme activity for phosphatidylethanolamine than
CC       phosphatidylcholine (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- ENZYME REGULATION: Stimulated by cytosolic Ca(2+). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol. Lysosome membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250};
CC       Cytoplasmic side {ECO:0000250}. Note=Translocates to lysosomal
CC       membranes in a calcium-dependent fashion. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q68DD2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q68DD2-2; Sequence=VSP_019888, VSP_019889;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q68DD2-3; Sequence=VSP_019887;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The N-terminal C2 domain associates with lipid membranes
CC       upon calcium binding. It modulates enzyme activity by presenting
CC       the active site to its substrate in response to elevations of
CC       cytosolic Ca(2+) (By similarity). {ECO:0000250}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK172836; BAD18801.1; -; mRNA.
DR   EMBL; AC036103; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR749451; CAH18288.1; -; mRNA.
DR   CCDS; CCDS32204.1; -. [Q68DD2-1]
DR   RefSeq; NP_998765.3; NM_213600.3. [Q68DD2-1]
DR   UniGene; Hs.231873; -.
DR   ProteinModelPortal; Q68DD2; -.
DR   SMR; Q68DD2; -.
DR   BioGrid; 129083; 1.
DR   IntAct; Q68DD2; 1.
DR   STRING; 9606.ENSP00000371833; -.
DR   iPTMnet; Q68DD2; -.
DR   PhosphoSitePlus; Q68DD2; -.
DR   BioMuta; PLA2G4F; -.
DR   DMDM; 317373489; -.
DR   MaxQB; Q68DD2; -.
DR   PaxDb; Q68DD2; -.
DR   PeptideAtlas; Q68DD2; -.
DR   PRIDE; Q68DD2; -.
DR   Ensembl; ENST00000397272; ENSP00000380442; ENSG00000168907. [Q68DD2-1]
DR   GeneID; 255189; -.
DR   KEGG; hsa:255189; -.
DR   UCSC; uc001zoz.4; human. [Q68DD2-1]
DR   CTD; 255189; -.
DR   GeneCards; PLA2G4F; -.
DR   H-InvDB; HIX0202165; -.
DR   HGNC; HGNC:27396; PLA2G4F.
DR   HPA; HPA042713; -.
DR   HPA; HPA056752; -.
DR   neXtProt; NX_Q68DD2; -.
DR   OpenTargets; ENSG00000168907; -.
DR   PharmGKB; PA142671170; -.
DR   eggNOG; KOG1028; Eukaryota.
DR   eggNOG; KOG1325; Eukaryota.
DR   eggNOG; ENOG410XR72; LUCA.
DR   GeneTree; ENSGT00550000074489; -.
DR   HOGENOM; HOG000231788; -.
DR   HOVERGEN; HBG080412; -.
DR   InParanoid; Q68DD2; -.
DR   KO; K16342; -.
DR   OMA; GMWGSAF; -.
DR   OrthoDB; EOG091G01HN; -.
DR   PhylomeDB; Q68DD2; -.
DR   TreeFam; TF325228; -.
DR   Reactome; R-HSA-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-HSA-1482801; Acyl chain remodelling of PS.
DR   Reactome; R-HSA-1482839; Acyl chain remodelling of PE.
DR   Reactome; R-HSA-1482922; Acyl chain remodelling of PI.
DR   Reactome; R-HSA-1482925; Acyl chain remodelling of PG.
DR   Reactome; R-HSA-1483115; Hydrolysis of LPC.
DR   GenomeRNAi; 255189; -.
DR   PRO; PR:Q68DD2; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000168907; -.
DR   CleanEx; HS_PLA2G4F; -.
DR   ExpressionAtlas; Q68DD2; baseline and differential.
DR   Genevisible; Q68DD2; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032587; C:ruffle membrane; IEA:Ensembl.
DR   GO; GO:0031982; C:vesicle; IEA:Ensembl.
DR   GO; GO:0047498; F:calcium-dependent phospholipase A2 activity; IEA:Ensembl.
DR   GO; GO:0004622; F:lysophospholipase activity; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008970; F:phosphatidylcholine 1-acylhydrolase activity; TAS:Reactome.
DR   GO; GO:0004623; F:phospholipase A2 activity; TAS:Reactome.
DR   GO; GO:0050482; P:arachidonic acid secretion; IEA:Ensembl.
DR   GO; GO:0071236; P:cellular response to antibiotic; IEA:Ensembl.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0009395; P:phospholipid catabolic process; IEA:InterPro.
DR   GO; GO:0006644; P:phospholipid metabolic process; TAS:Reactome.
DR   GO; GO:0001516; P:prostaglandin biosynthetic process; IEA:Ensembl.
DR   Gene3D; 2.60.40.150; -; 1.
DR   InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR002642; LysoPLipase_cat_dom.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF01735; PLA2_B; 1.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00022; PLAc; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF52151; SSF52151; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS51210; PLA2C; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calcium; Complete proteome; Cytoplasm;
KW   Hydrolase; Lipid degradation; Lipid metabolism; Lysosome; Membrane;
KW   Metal-binding; Polymorphism; Reference proteome.
FT   CHAIN         1    849       Cytosolic phospholipase A2 zeta.
FT                                /FTId=PRO_0000247027.
FT   DOMAIN       31    133       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   DOMAIN      306    849       PLA2c. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00555}.
FT   ACT_SITE    395    395       Nucleophile. {ECO:0000250}.
FT   ACT_SITE    680    680       Proton acceptor. {ECO:0000250}.
FT   VAR_SEQ     352    352       G -> GQV (in isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_019887.
FT   VAR_SEQ     433    454       ALSTERLQYYTQELGVRERSGH -> DVRVSPCQLPRLHSS
FT                                NLDHSLW (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_019888.
FT   VAR_SEQ     455    849       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_019889.
FT   VARIANT      30     30       G -> V (in dbSNP:rs636604).
FT                                /FTId=VAR_053553.
FT   VARIANT     740    740       M -> V (in dbSNP:rs1356410).
FT                                {ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_027054.
FT   CONFLICT    203    203       R -> G (in Ref. 1; BAD18801).
FT                                {ECO:0000305}.
FT   CONFLICT    262    262       A -> T (in Ref. 1; BAD18801).
FT                                {ECO:0000305}.
FT   CONFLICT    363    363       G -> E (in Ref. 3; CAH18288).
FT                                {ECO:0000305}.
SQ   SEQUENCE   849 AA;  95082 MW;  B2231EC3A9494598 CRC64;
     MLWALWPRWL ADKMLPLLGA VLLQKREKRG PLWRHWRRET YPYYDLQVKV LRATNIRGTD
     LLSKADCYVQ LWLPTASPSP AQTRIVANCS DPEWNETFHY QIHGAVKNVL ELTLYDKDIL
     GSDQLSLLLF DLRSLKCGQP HKHTFPLNHQ DSQELQVEFV LEKSQVPASE VITNGVLVAH
     PCLRIQGTLR GDGTAPREEY GSRQLQLAVP GAYEKPQLLP LQPPTEPGLP PTFTFHVNPV
     LSSRLHVELM ELLAAVQSGP SAELEAQTSK LGEGGILLSS LPLGQEEQCS VALGEGQEVA
     LSMKVEMSSG DLDLRLGFDL SDGEQEFLDR RKQVVSKALQ QVLGLSEALD SGQVPVVAVL
     GSGGGTRAMS SLYGSLAGLQ ELGLLDTVTY LSGVSGSTWC ISTLYRDPAW SQVALQGPIE
     RAQVHVCSSK MGALSTERLQ YYTQELGVRE RSGHSVSLID LWGLLVEYLL YQEENPAKLS
     DQQEAVRQGQ NPYPIYTSVN VRTNLSGEDF AEWCEFTPYE VGFPKYGAYV PTELFGSELF
     MGRLLQLQPE PRICYLQGMW GSAFATSLDE IFLKTAGSGL SFLEWYRGSV NITDDCQKPQ
     LHNPSRLRTR LLTPQGPFSQ AVLDIFTSRF TSAQSFNFTR GLCLHKDYVA GREFVAWKDT
     HPDAFPNQLT PMRDCLYLVD GGFAINSPFP LALLPQRAVD LILSFDYSLE APFEVLKMTE
     KYCLDRGIPF PSIEVGPEDM EEARECYLFA KAEDPRSPIV LHFPLVNRTF RTHLAPGVER
     QTAEEKAFGD FVINRPDTPY GMMNFTYEPQ DFYRLVALSR YNVLNNVETL KCALQLALDR
     HQARERAGA
//
